Outcomes of corticosteroid therapy in patients with viral community-acquired pneumonia.

ABSTRACT:

Aim

The objective of this study was to assess the therapeutic effects of corticosteroids in adult patients hospitalized with viral community-acquired pneumonia.

Methods

This is a retrospective analysis of data collected prospectively from November 1996 to June 2024. All adult patients with viral community-acquired pneumonia were enrolled. The primary outcome was 30-day mortality. Secondary outcomes included all-cause in-hospital mortality, ICU admission, length of ICU and hospital stay, mechanical ventilation, and 1-year mortality. Propensity score matching (PSM) was used to obtain balance among the baseline variables in the two groups.

Results

Of the 524 patients with viral pneumonia, 30 (6%) received corticosteroids and 494 (94%) did not. Patients were primarily mal

SUBMITTER: Cilloniz C 

PROVIDER: S-EPMC11423511 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature